Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Meningitis | Research

Chronic meningitis in adults: a comparison between neurotuberculosis and neurobrucellosis

Authors: Matin Shirazinia, Fereshte Sheybani, HamidReza Naderi, Mahboubeh Haddad, Pouria Hajipour, Farzaneh Khoroushi

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

In regions endemic for tuberculosis and brucellosis, distinguishing between tuberculous meningitis (TBM) and brucella meningitis (BM) poses a substantial challenge. This study investigates the clinical and paraclinical characteristics of patients with TBM and BM.

Methods

Adult patients diagnosed with either TBM or BM who were admitted to two referral hospitals between March 2015 and October 2022, were included, and the characteristics of the patients were analyzed.

Results

Seventy patients formed the study group, 28 with TBM and 42 with BM, were included. TBM patients had a 2.06-fold (95% CI: 1.26 to 3.37, P-value: 0.003) higher risk of altered consciousness and a 4.80-fold (95% CI: 1.98 to 11.61, P-value: < 0.001) higher risk of extra-neural involvement as compared to BM patients. Cerebrospinal fluid (CSF) analysis revealed a significantly higher percentage of polymorphonuclear leukocytes (PMN) in TBM compared to BM (Standardized mean difference: 0.69, 95% CI: 0.18 to 1.20, P-value: 0.008). Neuroimaging findings indicated higher risks of hydrocephalus (P-value: 0.002), infarction (P-value: 0.029), and meningeal enhancement (P-value: 0.012) in TBM compared to BM. Moreover, TBM patients had a 67% (95% CI: 21% to 131%, P-value:0.002) longer median length of hospital stay and a significantly higher risk of unfavorable outcomes (Risk ratio: 6.96, 95% CI: 2.65 to 18.26, p < 0.001).

Conclusions

Our study emphasizes that TBM patients displayed increased frequencies of altered consciousness, PMN dominance in CSF, extra-neural involvement, hydrocephalus, meningeal enhancement, and brain infarction. The findings emphasize the diagnostic difficulties and underscore the importance of cautious differentiation between these two conditions to guide appropriate treatment strategies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zunt JR, Baldwin KJ. Chronic and subacute meningitis. CONTINUUM. 2012;18(6):1290–318.PubMed Zunt JR, Baldwin KJ. Chronic and subacute meningitis. CONTINUUM. 2012;18(6):1290–318.PubMed
2.
go back to reference Wilson MR, O’Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, et al. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. JAMA Neurol. 2018;75(8):947–55.CrossRefPubMed Wilson MR, O’Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, et al. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. JAMA Neurol. 2018;75(8):947–55.CrossRefPubMed
4.
go back to reference Hildebrand J, Aoun M. Chronic meningitis: still a diagnostic challenge. J Neurol. 2003;250(6):653–60.CrossRefPubMed Hildebrand J, Aoun M. Chronic meningitis: still a diagnostic challenge. J Neurol. 2003;250(6):653–60.CrossRefPubMed
5.
go back to reference Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993;17(6):987–94.CrossRefPubMed Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993;17(6):987–94.CrossRefPubMed
6.
go back to reference Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012;56(3):1523–8.CrossRefPubMedPubMedCentral Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012;56(3):1523–8.CrossRefPubMedPubMedCentral
7.
go back to reference Sheybani F, Haddad M, Shirazinia M. Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review. Future Neurol. 2023;18(4):FNL73.CrossRef Sheybani F, Haddad M, Shirazinia M. Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review. Future Neurol. 2023;18(4):FNL73.CrossRef
8.
go back to reference Gul HC, Erdem H. Brucellosis (brucella species). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. edn.: Elsevier; 2015: 2584–2589. e2583. Gul HC, Erdem H. Brucellosis (brucella species). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. edn.: Elsevier; 2015: 2584–2589. e2583.
9.
go back to reference Erdem H, Senbayrak S, Gencer S, Hasbun R, Karahocagil MK, Sengoz G, Karsen H, Kaya S, Civljak R, Inal AS, et al. Tuberculous and brucellosis meningitis differential diagnosis. Travel Med Infect Dis. 2015;13(2):185–91.CrossRefPubMed Erdem H, Senbayrak S, Gencer S, Hasbun R, Karahocagil MK, Sengoz G, Karsen H, Kaya S, Civljak R, Inal AS, et al. Tuberculous and brucellosis meningitis differential diagnosis. Travel Med Infect Dis. 2015;13(2):185–91.CrossRefPubMed
10.
go back to reference Erdem H, Ozturk-Engin D, Elaldi N, Gulsun S, Sengoz G, Crisan A, Johansen IS, Inan A, Nechifor M, Al-Mahdawi A, et al. The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study. Clin Microbiol Infect. 2014;20(10):O600-608.CrossRefPubMed Erdem H, Ozturk-Engin D, Elaldi N, Gulsun S, Sengoz G, Crisan A, Johansen IS, Inan A, Nechifor M, Al-Mahdawi A, et al. The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study. Clin Microbiol Infect. 2014;20(10):O600-608.CrossRefPubMed
12.
go back to reference Hajia M, Rahbar M, Taghavi AH. Brucellosis antibody level of hospitalized patients in Hamadan. Western Iran Shiraz E-Med J. 2007;8(3):127–31. Hajia M, Rahbar M, Taghavi AH. Brucellosis antibody level of hospitalized patients in Hamadan. Western Iran Shiraz E-Med J. 2007;8(3):127–31.
13.
go back to reference Chalabiani S, Khodadad Nazari M, Razavi Davoodi N, Shabani M, Mardani M, Sarafnejad A, Akbar Amirzargar A. The Prevalence of Brucellosis in Different Provinces of Iran during 2013–2015. Iran J Public Health. 2019;48(1):132–8.PubMedPubMedCentral Chalabiani S, Khodadad Nazari M, Razavi Davoodi N, Shabani M, Mardani M, Sarafnejad A, Akbar Amirzargar A. The Prevalence of Brucellosis in Different Provinces of Iran during 2013–2015. Iran J Public Health. 2019;48(1):132–8.PubMedPubMedCentral
14.
go back to reference Alavi S, Motlagh M. A review of epidemiology, diagnosis and management of brucellosis for general physicians working in the Iranian health network. Jundishapur J Microbiol. 2012;5(2):384–7.CrossRef Alavi S, Motlagh M. A review of epidemiology, diagnosis and management of brucellosis for general physicians working in the Iranian health network. Jundishapur J Microbiol. 2012;5(2):384–7.CrossRef
15.
go back to reference Guven T, Ugurlu K, Ergonul O, Celikbas AK, Gok SE, Comoglu S, Baykam N, Dokuzoguz B. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis. 2013;56(10):1407–12.CrossRefPubMed Guven T, Ugurlu K, Ergonul O, Celikbas AK, Gok SE, Comoglu S, Baykam N, Dokuzoguz B. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis. 2013;56(10):1407–12.CrossRefPubMed
16.
go back to reference Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, Donald PR, Wilkinson RJ, Marais BJ. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803–12.CrossRefPubMed Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, Donald PR, Wilkinson RJ, Marais BJ. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803–12.CrossRefPubMed
17.
go back to reference Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;305(7905):480–4.CrossRef Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;305(7905):480–4.CrossRef
18.
go back to reference Linden A. esizereg: Stata module for computing the effect size based on a linear regression coefficient. 2021. Linden A. esizereg: Stata module for computing the effect size based on a linear regression coefficient. 2021.
19.
go back to reference Erdem H, Kilic S, Sener B, Acikel C, Alp E, Karahocagil M, Yetkin F, Inan A, Kecik-Bosnak V, Gul HC, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013;19(2):E80-86.CrossRefPubMed Erdem H, Kilic S, Sener B, Acikel C, Alp E, Karahocagil M, Yetkin F, Inan A, Kecik-Bosnak V, Gul HC, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013;19(2):E80-86.CrossRefPubMed
21.
go back to reference Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. Am J Neuroradiol. 2004;25(3):395–401.PubMedPubMedCentral Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. Am J Neuroradiol. 2004;25(3):395–401.PubMedPubMedCentral
22.
go back to reference García-Grimshaw M, Gutiérrez-Manjarrez FA, Navarro-Álvarez S, González-Duarte A. Clinical, imaging, and laboratory characteristics of adult Mexican patients with tuberculous meningitis: a retrospective cohort study. J Epidemiol Global Health. 2020;10(1):59.CrossRef García-Grimshaw M, Gutiérrez-Manjarrez FA, Navarro-Álvarez S, González-Duarte A. Clinical, imaging, and laboratory characteristics of adult Mexican patients with tuberculous meningitis: a retrospective cohort study. J Epidemiol Global Health. 2020;10(1):59.CrossRef
23.
go back to reference Sinner SW, Tunkel AR. Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep. 2002;4(4):324–31.CrossRefPubMed Sinner SW, Tunkel AR. Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep. 2002;4(4):324–31.CrossRefPubMed
24.
go back to reference Bourgi K, Fiske C, Sterling TR. Tuberculosis meningitis. Curr Infect Dis Rep. 2017;19:1–9.CrossRef Bourgi K, Fiske C, Sterling TR. Tuberculosis meningitis. Curr Infect Dis Rep. 2017;19:1–9.CrossRef
25.
go back to reference Chan K, Cheung R, Fong C, Tsang K, Mak W, Ho S. Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis. QJM. 2003;96(9):643–8.CrossRefPubMed Chan K, Cheung R, Fong C, Tsang K, Mak W, Ho S. Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis. QJM. 2003;96(9):643–8.CrossRefPubMed
26.
go back to reference Özateş M, Kemaloglu S, Gürkan F, Özkan Ü, Hoşoglu S, Şimşek M. CT of the brain in tuberculous meningitis: a review of 289 patients. Acta Radiol. 2000;41(1):13–7.CrossRefPubMed Özateş M, Kemaloglu S, Gürkan F, Özkan Ü, Hoşoglu S, Şimşek M. CT of the brain in tuberculous meningitis: a review of 289 patients. Acta Radiol. 2000;41(1):13–7.CrossRefPubMed
27.
go back to reference Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022;269(7):3482–94.CrossRefPubMedPubMedCentral Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022;269(7):3482–94.CrossRefPubMedPubMedCentral
28.
go back to reference Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13(6):e339–43.CrossRefPubMed Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13(6):e339–43.CrossRefPubMed
29.
go back to reference Wen L, Li M, Xu T, Yu X, Wang L, Li K. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. J Neurol. 2019;266(12):3009–21.CrossRefPubMed Wen L, Li M, Xu T, Yu X, Wang L, Li K. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. J Neurol. 2019;266(12):3009–21.CrossRefPubMed
30.
go back to reference Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):947–57.CrossRefPubMed Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):947–57.CrossRefPubMed
31.
go back to reference Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4(4):CD002244.PubMed Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4(4):CD002244.PubMed
32.
go back to reference Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther. 2007;5(6):983–90.CrossRefPubMed Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther. 2007;5(6):983–90.CrossRefPubMed
Metadata
Title
Chronic meningitis in adults: a comparison between neurotuberculosis and neurobrucellosis
Authors
Matin Shirazinia
Fereshte Sheybani
HamidReza Naderi
Mahboubeh Haddad
Pouria Hajipour
Farzaneh Khoroushi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09345-6

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.